SCF AEIC TARGET PRIORITY MATRIX | HIV/AIDS-Equivalent Immune Collapse (AEIC)

Document Code: SCF-AEIC-TPM-0001

Framework: SCF Multi-Omic Target Prioritization Engine

Dataset Source: SCF AEIC Gene Library (350 Genes)

Purpose: Drug-Target Prioritization for API Discovery and Therapeutic Stack Engineering

1. Scope and Positioning

The SCF AEIC Target Priority Matrix ranks gene targets according to their therapeutic leverage within the AEIC multi-omic failure architecture.

Targets are evaluated using the SCF prioritization engine combining:

Pathway Centrality Index (PCI) – network control power
Drugability Index (DI) – availability of targetable pockets or existing pharmacology
Fault Tier Impact Score (FTIS) – ability to reverse core AEIC collapse domains
Resistance Prevention Index (RPI) – multi-target robustness potential
Safety Modulation Score (SMS) – expected therapeutic window

Composite Score:

SCF-TPS (Target Priority Score)

SCF-TPS = PCI + DI + FTIS + RPI + SMS

Maximum theoretical score: 25

2. Target Priority Classification

SCF TPS Score	Priority Tier	Development Role
21–25	Tier-1 Strategic Target	Core therapeutic anchor
17–20	Tier-2 High Value Target	Combination therapy driver
13–16	Tier-3 Support Target	pathway stabilizer
9–12	Tier-4 Auxiliary Target	biomarker / indirect modulation
≤8	Tier-5 Exploratory	low therapeutic leverage

3. Tier-1 Strategic Targets (Core AEIC Control Nodes)

Gene	SCF Class	Primary Function	SCF TPS
CCR5	Viral Entry	host entry receptor	24
CXCR4	Viral Entry	viral tropism receptor	23
PDCD1 (PD-1)	Immune Exhaustion	T-cell inhibition	23
CTLA4	Immune Checkpoint	immune suppression	22
IL2	Cytokine Circuit	T-cell proliferation	22
IL7	Cytokine Circuit	T-cell survival	22
TNF	Cytokine Circuit	immune activation	21
MTOR	Metabolic Control	immune metabolic regulation	22
PRKAA1 (AMPK)	Metabolic Control	energy homeostasis	22
AHR	Xenobiotic Response	immune suppression signaling	21
APOBEC3G	Antiviral Defense	viral restriction factor	21
IFITM3	Antiviral Defense	viral membrane restriction	21

Strategic Role

These targets regulate:

viral entry
immune exhaustion
metabolic collapse
antiviral restriction
xenobiotic-viral amplification

They form the primary intervention layer.

4. Tier-2 High-Value Targets

Gene	SCF Class	Function	SCF TPS
LAG3	Immune checkpoint	T-cell exhaustion	20
TIGIT	Immune checkpoint	immune suppression	19
IL15	Cytokine circuit	T-cell proliferation	19
IFNG	Cytokine signaling	antiviral response	20
STAT1	antiviral signaling	interferon pathway	20
STAT3	immune regulation	cytokine signaling	19
JAK1	cytokine signaling	immune signal relay	19
JAK2	cytokine signaling	immune signal relay	18
NF-κB (RELA)	transcription	immune activation	20
IRF7	interferon response	antiviral defense	19
TRIM5	antiviral restriction	viral capsid targeting	18
SAMHD1	viral replication control	dNTP regulation	18
BST2	viral release inhibitor	tetherin antiviral	19
HIF1A	metabolic stress response	immune metabolism	18

Strategic Role

Targets viral persistence and immune activation loops.

5. Tier-3 Support Targets

Gene	Class	Function	Score
CXCL10	chemokine	immune recruitment	16
CCL5	chemokine	T-cell migration	16
FOXP3	T-regulator	immune tolerance	15
SOCS1	immune regulation	cytokine feedback	16
SOCS3	immune regulation	cytokine suppression	15
SIRT1	metabolic regulation	mitochondrial stability	15
PGC1A	mitochondrial biogenesis	metabolic recovery	16
NRF2	oxidative defense	redox balance	16
KEAP1	redox regulation	oxidative stress control	15
MCL1	apoptosis regulation	T-cell survival	15
BCL2	apoptosis regulation	cell survival	16
CASP8	apoptosis signaling	immune cell death	15
RIPK1	necroptosis	inflammatory death pathway	14
NLRP3	inflammasome	immune activation	15

6. Tier-4 Auxiliary Targets

Gene	Class	Function	Score
COL1A1	ECM scaffold	lymph node structure	12
COL3A1	ECM scaffold	immune tissue architecture	11
ITGB1	integrin	cell adhesion	11
VCAM1	adhesion	immune trafficking	12
ICAM1	adhesion	immune synapse	12
MMP9	ECM remodeling	lymph node degradation	11
TIMP1	ECM regulation	matrix stability	10
LOX	ECM crosslinking	fibrosis control	10

These targets influence immune microenvironment integrity.

7. Tier-5 Exploratory Targets

These genes are currently considered secondary modulators with lower direct therapeutic leverage.

Examples:

Gene

UGT1A1

CYP3A4

GSTM1

GPX4

HSP90

HSP70

MAPK1

MAPK8

MAPK14

Their value lies primarily in:

drug metabolism
stress signaling
toxicity modulation

8. Multi-Omic Target Distribution

Omics Layer	Tier-1 Targets
Genomic	CCR5, CXCR4
Transcriptomic	RELA
Epigenomic	AHR
Proteomic	PDCD1, CTLA4
Metabolomic	AMPK, MTOR
Interactomic	STAT1, JAK1
Connectomic	IFNG
Biomechanical	ECM genes

9. SCF Therapeutic Target Strategy

Primary Intervention Layer

Targets controlling infection and immune collapse

CCR5
CXCR4
PD-1
IL2
IL7
AMPK
mTOR

Immune Restoration Layer

IFNG
STAT1
IL15
IRF7

Antiviral Restriction Layer

APOBEC3G
IFITM3
TRIM5
BST2

Metabolic Recovery Layer

AMPK
SIRT1
PGC1A
NRF2

10. Translational Application

The Target Priority Matrix supports:

API Discovery

identifying molecular scaffolds targeting Tier-1 nodes.

Combination Therapy Design

multi-target therapeutic stacks preventing viral escape.

Biomarker Development

monitoring immune recovery and metabolic restoration.

Clinical Trial Stratification

target-response patient profiling.

11. Recommended Next SCF Dataset

Next stage of SCF pipeline:

SCF AEIC API DISCOVERY MAP

This document converts the Tier-1 and Tier-2 targets into:

candidate drug scaffolds
botanical molecule matches
synthetic small molecule design
synergistic stacks

12. SCF Master Registry Index

SCF-AEIC-TPM-0001

SCF-AEIC-GL-0001

SCF-GCA-AEIC-0001

SCF-SEF-MD-0001

SCF-API-DP-0001

SCF-PP-UVT-0001

SCF-CRD-WORKFLOW-0001

SCF-VECTIS-409-PIPELINE-0001

SCF AEIC TARGET PRIORITY MATRIX | HIV/AIDS-Equivalent Immune Collapse (AEIC)

Document Code: SCF-AEIC-TPM-0001

Framework: SCF Multi-Omic Target Prioritization Engine

Dataset Source: SCF AEIC Gene Library (350 Genes)

Purpose: Drug-Target Prioritization for API Discovery and Therapeutic Stack Engineering

1. Scope and Positioning

The SCF AEIC Target Priority Matrix ranks gene targets according to their therapeutic leverage within the AEIC multi-omic failure architecture.

Targets are evaluated using the SCF prioritization engine combining:

Pathway Centrality Index (PCI) – network control power
Drugability Index (DI) – availability of targetable pockets or existing pharmacology
Fault Tier Impact Score (FTIS) – ability to reverse core AEIC collapse domains
Resistance Prevention Index (RPI) – multi-target robustness potential
Safety Modulation Score (SMS) – expected therapeutic window

Composite Score:

SCF-TPS (Target Priority Score)

SCF-TPS = PCI + DI + FTIS + RPI + SMS

Maximum theoretical score: 25

2. Target Priority Classification

SCF TPS Score	Priority Tier	Development Role
21–25	Tier-1 Strategic Target	Core therapeutic anchor
17–20	Tier-2 High Value Target	Combination therapy driver
13–16	Tier-3 Support Target	pathway stabilizer
9–12	Tier-4 Auxiliary Target	biomarker / indirect modulation
≤8	Tier-5 Exploratory	low therapeutic leverage

3. Tier-1 Strategic Targets (Core AEIC Control Nodes)

Gene	SCF Class	Primary Function	SCF TPS
CCR5	Viral Entry	host entry receptor	24
CXCR4	Viral Entry	viral tropism receptor	23
PDCD1 (PD-1)	Immune Exhaustion	T-cell inhibition	23
CTLA4	Immune Checkpoint	immune suppression	22
IL2	Cytokine Circuit	T-cell proliferation	22
IL7	Cytokine Circuit	T-cell survival	22
TNF	Cytokine Circuit	immune activation	21
MTOR	Metabolic Control	immune metabolic regulation	22
PRKAA1 (AMPK)	Metabolic Control	energy homeostasis	22
AHR	Xenobiotic Response	immune suppression signaling	21
APOBEC3G	Antiviral Defense	viral restriction factor	21
IFITM3	Antiviral Defense	viral membrane restriction	21

Strategic Role

These targets regulate:

viral entry
immune exhaustion
metabolic collapse
antiviral restriction
xenobiotic-viral amplification

They form the primary intervention layer.

4. Tier-2 High-Value Targets

Gene	SCF Class	Function	SCF TPS
LAG3	Immune checkpoint	T-cell exhaustion	20
TIGIT	Immune checkpoint	immune suppression	19
IL15	Cytokine circuit	T-cell proliferation	19
IFNG	Cytokine signaling	antiviral response	20
STAT1	antiviral signaling	interferon pathway	20
STAT3	immune regulation	cytokine signaling	19
JAK1	cytokine signaling	immune signal relay	19
JAK2	cytokine signaling	immune signal relay	18
NF-κB (RELA)	transcription	immune activation	20
IRF7	interferon response	antiviral defense	19
TRIM5	antiviral restriction	viral capsid targeting	18
SAMHD1	viral replication control	dNTP regulation	18
BST2	viral release inhibitor	tetherin antiviral	19
HIF1A	metabolic stress response	immune metabolism	18

Strategic Role

Targets viral persistence and immune activation loops.

5. Tier-3 Support Targets

Gene	Class	Function	Score
CXCL10	chemokine	immune recruitment	16
CCL5	chemokine	T-cell migration	16
FOXP3	T-regulator	immune tolerance	15
SOCS1	immune regulation	cytokine feedback	16
SOCS3	immune regulation	cytokine suppression	15
SIRT1	metabolic regulation	mitochondrial stability	15
PGC1A	mitochondrial biogenesis	metabolic recovery	16
NRF2	oxidative defense	redox balance	16
KEAP1	redox regulation	oxidative stress control	15
MCL1	apoptosis regulation	T-cell survival	15
BCL2	apoptosis regulation	cell survival	16
CASP8	apoptosis signaling	immune cell death	15
RIPK1	necroptosis	inflammatory death pathway	14
NLRP3	inflammasome	immune activation	15

6. Tier-4 Auxiliary Targets

Gene	Class	Function	Score
COL1A1	ECM scaffold	lymph node structure	12
COL3A1	ECM scaffold	immune tissue architecture	11
ITGB1	integrin	cell adhesion	11
VCAM1	adhesion	immune trafficking	12
ICAM1	adhesion	immune synapse	12
MMP9	ECM remodeling	lymph node degradation	11
TIMP1	ECM regulation	matrix stability	10
LOX	ECM crosslinking	fibrosis control	10

These targets influence immune microenvironment integrity.

7. Tier-5 Exploratory Targets

These genes are currently considered secondary modulators with lower direct therapeutic leverage.

Examples:

Gene

UGT1A1

CYP3A4

GSTM1

GPX4

HSP90

HSP70

MAPK1

MAPK8

MAPK14

Their value lies primarily in:

drug metabolism
stress signaling
toxicity modulation

8. Multi-Omic Target Distribution

Omics Layer	Tier-1 Targets
Genomic	CCR5, CXCR4
Transcriptomic	RELA
Epigenomic	AHR
Proteomic	PDCD1, CTLA4
Metabolomic	AMPK, MTOR
Interactomic	STAT1, JAK1
Connectomic	IFNG
Biomechanical	ECM genes

9. SCF Therapeutic Target Strategy

Primary Intervention Layer

Targets controlling infection and immune collapse

CCR5
CXCR4
PD-1
IL2
IL7
AMPK
mTOR

Immune Restoration Layer

IFNG
STAT1
IL15
IRF7

Antiviral Restriction Layer

APOBEC3G
IFITM3
TRIM5
BST2

Metabolic Recovery Layer

AMPK
SIRT1
PGC1A
NRF2

10. Translational Application

The Target Priority Matrix supports:

API Discovery

identifying molecular scaffolds targeting Tier-1 nodes.

Combination Therapy Design

multi-target therapeutic stacks preventing viral escape.

Biomarker Development

monitoring immune recovery and metabolic restoration.

Clinical Trial Stratification

target-response patient profiling.

11. Recommended Next SCF Dataset

Next stage of SCF pipeline:

SCF AEIC API DISCOVERY MAP

This document converts the Tier-1 and Tier-2 targets into:

candidate drug scaffolds
botanical molecule matches
synthetic small molecule design
synergistic stacks

12. SCF Master Registry Index

SCF-AEIC-TPM-0001

SCF-AEIC-GL-0001

SCF-GCA-AEIC-0001

SCF-SEF-MD-0001

SCF-API-DP-0001

SCF-PP-UVT-0001

SCF-CRD-WORKFLOW-0001

SCF-VECTIS-409-PIPELINE-0001